Clinical trial
Sodium Channel Splicing in Heart Failure Trial (SOCS-HEFT) Prospective Study
NCT02738749 is registered in ClinicalTrials.gov with Rhode Island Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Sodium Channel Splicing in Heart Failure Trial (SOCS-HEFT) Prospective Study
- Lead sponsor
- Rhode Island Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- June 30, 2014
- Completion date
- July 31, 2020
- Enrollment
- 450 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.